Perfluorohexanoic acid (PFHxA)

If you drink from a private well, live near an airport or industrial site, or work around firefighting foam or fluorinated materials, this test can show whether a newer forever chemical is moving through your body right now. Because this particular chemical clears in weeks rather than years, a detectable result points to recent, ongoing exposure that you may still be able to trace and cut off.

This is an early, exploratory measurement, not a diagnosis. It tells you about contact with a chemical, not about a disease you already have.

What This Test Actually Measures

The test measures PFHxA (perfluorohexanoic acid), a short-chain, six-carbon member of the PFAS family (a large group of man-made forever chemicals used to make products water, grease, and stain resistant). Your body does not make this molecule. It arrives entirely from the outside world and can also form when related fluorinated chemicals break down.

It appears in urine because your kidneys are the main exit route for short-chain PFAS like this one. So a urine result reflects two things at once: how much you have been exposed to, and how your kidneys are clearing it. It does not measure any process your body runs on its own.

A Signal of Recent Exposure, Not Long-Term Buildup

The most useful thing to know about this chemical is that it does not stick around. Its half-life (the time your body needs to clear half of a substance) is estimated at about 32 days in one group of exposed workers, and roughly a day and a half after a single controlled oral dose in a one-person pilot study. It is not considered to build up in the body the way legacy PFAS do.

That is a sharp contrast with the well-known PFAS such as PFOS, PFOA, and PFHxS (a chemically similar but separate compound), which can linger in the blood for years. Practically, this means a detectable urine result is a fresh signal. It points to exposure happening recently or continuously, not to something you picked up long ago.

How Often It Shows Up in Urine

In the general U.S. population, urinary levels are usually low or absent. In a national survey of about 2,700 people, this chemical was detected in 22.6% of urine samples, and most participants (67.5%) had no detectable PFAS in urine at all. Even in the highest tenth of the population, concentrations sat around 0.3 micrograms per liter, a very small amount. A later national review reported nearly the same detection rate, 22.7%.

Children in certain settings show much more consistent detection. In one Austrian children's survey it was found in every urine sample, though at a tiny median of 0.004 micrograms per liter, and in a study of about 189 Shanghai children it was detected in 100% of samples at a median of 20.20 nanograms per liter. In Hong Kong preschoolers, it was present in at least a third of samples. Detection depends heavily on where you live and how sensitive the lab method is.

Where It Comes From

This chemical is an impurity, breakdown product, and byproduct of fluorotelomer-based products that have been on the market since the 1970s. It also turns up in fluorinated polymer manufacturing, firefighting foams, water- and grease-repellent coatings, and food and pharmaceutical packaging.

Food and drinking water are major routes of PFAS exposure overall, and indoor dust and treated household surfaces appear relevant for short-chain compounds like this one. Contaminated water near airfields and military sites where firefighting foam was used is a documented high-exposure source. In the general public, this chemical is only infrequently found in drinking water, so for most people it is not a dominant water contaminant.

What Higher Levels Might Mean for Health

Honest answer: the direct human evidence tying urinary levels of this specific chemical to any disease is thin. It is detected too rarely and at concentrations too low for it to have been studied much on its own, and researchers repeatedly flag it as a compound that needs more investigation rather than one with proven human effects.

The clearest toxicity signal comes from animal studies, where high, chronic doses damaged the kidneys of rats, producing tissue injury in the filtering structures only at the highest dose tested. Reviewers describe the kidney as the likely target organ, but they also stress that these effects are mild or reversible and appear only at doses far higher than those that harm the older PFAS. The dose used to set a safe reference level is roughly ten thousand times higher than the equivalent for PFOA. This is animal evidence, and it has not been confirmed to apply to the low levels most people carry.

Where this chemical shows up in human disease studies, it is usually as one member of a PFAS mixture rather than the main driver, and often in a different sample type. A case-control study reported that higher plasma (not urine) levels were associated with about 2.6 times higher odds of childhood congenital heart disease, but that finding is from blood, not this test. In a study of urinary PFAS and thyroid disease, short-chain PFAS were linked to nodular goiter and papillary thyroid cancer, yet the dominant contributor was PFHxS, not this compound. For now, a result here is best read as an exposure marker, not a disease indicator.

Why One Reading Is Not Enough

This is exactly the kind of marker where the trend matters more than any single number. Because it clears within weeks, a level today largely reflects the last stretch of exposure, and it can swing based on how hydrated you were when you gave the sample. One reading is a snapshot of a moving target.

The practical value comes from retesting. If you find a detectable level, change something (switch your water source, remove a suspected product), then retest in about 2 to 3 months, a falling number is real-world confirmation that you cut off the source. Get a baseline, act on it, and recheck. Since standardized clinical cutpoints do not exist for this marker, your own trend line is the most meaningful comparison you have.

What to Do With an Unexpected Result

A detectable or rising result is a prompt to investigate exposure, not to panic. The first move is to confirm it with a repeat sample, since a single spot urine can be diluted or influenced by timing. Then look for the source: test your drinking water, review your occupational and household exposures, and consider that a specific product or site may be the culprit.

Because urine is not the strongest matrix for judging overall PFAS body burden, pairing this with a serum PFAS panel gives a fuller picture, and for this chemical specifically, whole blood may capture it better than serum since it binds more to blood cells. Ordering kidney markers alongside it (cystatin C, an eGFR estimate of filtering rate, and a urine albumin-to-creatinine ratio) adds context, because kidney function shapes how the chemical is cleared. If exposure looks substantial, an environmental or occupational medicine clinician is the right person to help you sort out the source and next steps.

When a Single Reading Can Fool You

Two things distort a urine result more than anything else. The first is dilution: drinking a lot of water right before the test thins your urine and can lower the reading, which is why a first-morning sample is more reliable and why labs often report results both per liter and normalized to urine creatinine (a marker used to correct for how concentrated the sample is).

The second is the matrix itself. This chemical is the most frequently detected PFAS in urine, yet national investigators concluded that urine is not a good tool for tracking short-chain PFAS across the general population, because most people simply have levels too low to detect. A non-detectable urine result does not prove zero exposure. It may only mean the level fell below what the method could see.